Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GALCANEZUMAB-GNLM Cause Dysphonia? 64 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 64 reports of Dysphonia have been filed in association with GALCANEZUMAB-GNLM. This represents 0.2% of all adverse event reports for GALCANEZUMAB-GNLM.

64
Reports of Dysphonia with GALCANEZUMAB-GNLM
0.2%
of all GALCANEZUMAB-GNLM reports
0
Deaths
6
Hospitalizations

How Dangerous Is Dysphonia From GALCANEZUMAB-GNLM?

Of the 64 reports, 6 (9.4%) required hospitalization, and 2 (3.1%) were considered life-threatening.

Is Dysphonia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GALCANEZUMAB-GNLM. However, 64 reports have been filed with the FAERS database.

What Other Side Effects Does GALCANEZUMAB-GNLM Cause?

Injection site pain (6,622) Underdose (2,909) Migraine (2,612) Headache (2,104) Drug ineffective (1,610) Product dose omission issue (1,591) Injection site haemorrhage (1,415) Accidental underdose (1,064) Injection site erythema (1,052) Injection site pruritus (774)

What Other Drugs Cause Dysphonia?

FLUTICASONE\SALMETEROL (1,729) CABOZANTINIB S-MALATE (1,229) ADALIMUMAB (1,216) BUDESONIDE\FORMOTEROL (1,204) FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (1,143) ALBUTEROL (1,114) LENVATINIB (1,021) FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (943) LENALIDOMIDE (931) AMIKACIN (914)

Which GALCANEZUMAB-GNLM Alternatives Have Lower Dysphonia Risk?

GALCANEZUMAB-GNLM vs GALLIUM GA-OZETOTIDE GALCANEZUMAB-GNLM vs GALSULFASE GALCANEZUMAB-GNLM vs GAMMAGARD LIQUID GALCANEZUMAB-GNLM vs GANAXOLONE GALCANEZUMAB-GNLM vs GANCICLOVIR

Related Pages

GALCANEZUMAB-GNLM Full Profile All Dysphonia Reports All Drugs Causing Dysphonia GALCANEZUMAB-GNLM Demographics